TABLE 1.
Antibodies | Model(s) | Disease(s) | References |
---|---|---|---|
BHQ880 | 5T2MM murine model of myeloma | MM | Heath et al. (2009) |
SCID-hu mouse model of human myeloma | MM | Fulciniti et al. (2009) | |
Orthotopic patient-derived xenograft model of osteosarcoma | Osteosarcoma | Goldstein et al. (2016) | |
DKN-01 | Patients with relapsed/refractory esophagogastric cancer | Esophagogastric cancer | Wall et al. (2020) |
Patients with biliary tract cancer | Biliary tract cancer | Goyal et al. (2020) | |
C57BL/6 mice | Ovarian cancer | Betella et al. (2019) | |
ID8 syngeneic mice | Epithelial ovarian cancer | Betella et al. (2020) | |
Patients with MM or advanced solid tumors | MM or advanced solid tumors | Ryan et al. (2016) | |
Gynecologic malignancy patients | Gynecologic malignancies | Arend et al. (2019a) | |
NSCLC patients | NSCLC | Edenfield et al. (2014) | |
RH2-18 | Ovariectomized C57BL/6NTac mice and rhesus macaques | Postmenopausal osteoporosis | Glantschnig et al. (2011) |
Hetero-DS | Femur fracture model in rats | Fracture | Florio et al. (2016) |
Cynomolgus monkey | Postmenopausal osteoporosis | Florio et al. (2016) |